Reunion Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Technology Digest.

Press releases published on November 10, 2026

an hour ago

BioSyent Schedules Q3 and YTD 2026 Earnings Release for November 17, 2026

Indeterminate GlobeNewswire

2 hours ago

Draganfly Announces Third Quarter Results

Indeterminate GlobeNewswire

2 hours ago

Agility Robotics Files Customary Registration Statements Following Completion of Business Combination

Indeterminate GlobeNewswire

2 hours ago

Datacentrex Reports Third Quarter 2026 Results and $30 Million Investment in Eagle LNG

Indeterminate GlobeNewswire

2 hours ago

iBio Reports Q1 Fiscal Year 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

Aro Biotherapeutics Reports Therapeutic Potential of Centyrin–CD40 siRNA Conjugate for the Treatment of Inflammatory Myositis

Indeterminate GlobeNewswire

2 hours ago

Palisade Bio Reports Third Quarter 2026 Financial Results and Advances PALI-2108 Phase 2 Clinical Development Programs

Indeterminate GlobeNewswire

3 hours ago

Anaptys Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Context Therapeutics Reports Third Quarter 2026 Financial Results and Pipeline Progress

Indeterminate GlobeNewswire

3 hours ago

Eupraxia Pharmaceuticals Establishes At-The-Market Offering Program

Indeterminate GlobeNewswire

3 hours ago

BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

3 hours ago

Marchex Returns to Revenue Growth and Profitability in Third Quarter 2026

Indeterminate GlobeNewswire

3 hours ago

Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates

Indeterminate GlobeNewswire

3 hours ago

Biomea Fusion Reports Third Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

3 hours ago

Autolus Therapeutics Presents Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

3 hours ago

Rigetti Computing Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

NextCure Provides Business Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

GigaCloud Technology Inc to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Fortress Biotech Announces an Exclusive License Agreement for FB-607 for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D)

Indeterminate GlobeNewswire

3 hours ago

Mobile Infrastructure Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire